查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1939067

生物防治：市场占有率分析、产业趋势与统计、成长预测（2026-2031）

Biological Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2025 年，生物防治市场价值将达到 40.1 亿美元，到 2031 年将达到 59.8 亿美元，高于 2026 年的 42.9 亿美元。

预计在预测期（2026-2031 年）内，复合年增长率将达到 6.89%。

生物防治市场-IMG1

经济高效的微生物平台、自动化昆虫养殖以及对传统农药日益增长的监管压力，正在加速生物农药在主要作物系统中的应用。亚太地区透过广泛的政府补贴计画推动全球需求，而非洲积极的粮食倡议则支撑着最快的成长前景。害虫对合成化学品的快速抗药性以及消费者对认证有机产品日益增长的偏好，持续推动目标面积的扩大。同时，发酵技术的创新和长效配方的开发正在缩小生物农药与传统化学农药的性能差距，使生物农药更具竞争力。

全球生物防治市场趋势与洞察

严格禁止使用剧毒合成农药

监管机构持续淘汰高风险化学品，并推广生物防治的即时方案。欧盟的「从农场到餐桌」战略要求到2030年将化学农药的使用量减少50%，而美国环保署（EPA）已从2024年起註销了40多种活性成分。巴西和印度也宣布了类似的法规，将于2024年生效，从而扩大了近期可用于生物防治的面积。这些政策措施鼓励生产者加速产品上市，并促使农民重新思考其作物保护方案，转向综合虫害管理（IPM）框架。

全球对经认证的有机农产品的需求不断增长

预计到2024年，全球有机食品销售额将达到1,340亿美元，其中美国、德国和中国的年增长率均超过8%。超级市场正在推行零残留供应商政策，迫使生产商采用生物添加剂以维持认证。有机食品的农场收购价通常比传统农产品高出20%至40%，这抵消了生物药品的高成本，并鼓励其在高价值园艺领域进一步应用。

许多活体产品的商业性保质期较短。

大多数微生物生物防治剂在冷藏条件下仅能存活两到四周，这需要高成本的低温运输物流系统，严重限制了其在电力供应不稳定地区的市场渗透。儘管包封技术和冷冻保护剂配方方面的最新进展在初步研究中显示出将产品保质期延长一倍的潜力，但这些改进与合成化学替代品所达到的多年稳定性相比仍相去甚远。

细分市场分析

2025年，大型生物防治产品在生物防治市场中占据主导地位，市场份额高达97.25%，这得益于数十年来有益昆虫生产的商业性发展以及服务于全球农业市场的成熟分销网络。该领域的领先地位源于其在田间应用中久经考验的有效性，以及农民对捕食性昆虫和寄生性天敌释放程序的熟悉程度。其中，对行栽作物系统中土壤害虫防治尤为有效的昆虫病原线虫，在大型生物防治产品类别中占据最大份额。同时，捕食性和寄生性天敌在温室等可控环境条件下也表现优异。

微生物製剂正成为一股新兴的成长引擎，预计2031年将以8.59%的复合年增长率成长。向微生物製剂的转变反映了发酵过程和製剂稳定性的技术进步，这些进步正在克服传统细菌和真菌生物防治剂的限制。近期监管部门核准的多菌株微生物产品扩大了其潜在应用范围，尤其是在高价值园艺作物领域，其精准施用能力使其能够获得较高的定价。其他微生物製剂，包括病毒和原生动物製剂，目前仍处于小众应用领域，但在传统方法失效的特定害虫群落中展现出良好的效果。按类型分類的细分市场表明，不同的生物防治机制正根据目标害虫的生物学特性和作物生产系统，找到最佳的商业性应用途径。

生物防治市场报告按类型（宏观生物防治、微观生物防治）、作物类型（经济作物、园艺作物、农田作物）和地区（非洲、亚太地区、欧洲、中东、北美、南美）进行细分。市场预测以价值（美元）和数量（公吨）为单位。

区域分析

到2025年，亚太地区将占据生物防治市场66.80%的份额，这反映了中国覆盖1.65亿公顷土地的强制性农药减量政策以及印度慷慨的补贴计画。中国的《国家农药减量行动计画》旨在2030年将化学农药的使用量减少40%，并资助省级培训中心开展田间规模的寄生性天敌释放示范。印度的《国家永续农业使命》正在资助30个区域生产基地，为小规模农户合作社提供微生物投入品。

预计到2031年，非洲将以10.44%的复合年增长率实现全球最快增速，这主要得益于各国政府将粮食安全目标与捐助者资助的永续性项目相结合。尼日利亚公私合营倡议旨在到2027年为200万小规模农户提供服务，而埃及正在建设15个本地生产中心，以减少对进口的依赖。本地生产能力将有助于供应更新鲜的产品，并避免低温运输缺口。

预计欧洲和北美将保持稳定成长，这得益于欧盟的「从农场到餐桌」战略和高端有机产业的发展。欧洲生物防治市场的规模受惠于通用农业政策（CAP）的补贴机制，可涵盖高达70%的产品成本。在北美，价值1,340亿美元的有机零售通路正在推动对生物作物保护的需求，其产品价格比传统产品高出20%至40%。

其他福利：

  • Excel格式的市场预测（ME）表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 调查范围
  • 调查方法

第二章 报告

第三章执行摘要和主要发现

第四章：主要产业趋势

  • 有机耕作面积
  • 人均有机产品支出
  • 法律规范
    • 澳洲
    • 巴西
    • 加拿大
    • 中国
    • 法国
    • 德国
    • 印度
    • 印尼
    • 义大利
    • 日本
    • 墨西哥
    • 荷兰
    • 菲律宾
    • 俄罗斯
    • 西班牙
    • 泰国
    • 土耳其
    • 英国
    • 我们
    • 越南
  • 价值炼和通路分析
  • 市场驱动因素
    • 严格禁止使用剧毒合成农药
    • 全球对经认证的有机农产品的需求不断增长
    • 害虫对传统杀虫剂的抗药性加速增强
    • 政府对引进综合虫害管理（IPM）和生物材料提供补贴
    • 昆虫养殖自动化降低了宏观生物养殖的成本
    • 一种突破性的捕食性细菌平台，专门针对植物病原体
  • 市场限制
    • 许多活体产品的商业性保质期很短。
    • 需要经过多个机构的漫长报名手续。
    • 用于生产下一代微生物製剂的无菌发酵设施产能有限
    • 微气候相关的效能差异会削弱农民的信心

第五章 市场规模和成长预测（价值和数量）

  • 形式
    • 宏观生物学
      • 生物体
        • 致病线虫
        • 寄生天敌
        • 掠食者
    • 微生物
      • 生物体
        • 细菌生物防治剂
        • 真菌生物防治剂
        • 其他微生物
  • 作物类型
    • 经济作物
    • 园艺作物
    • 田间作物
  • 按地区
    • 非洲
      • 按国家/地区
        • 埃及
        • 奈及利亚
        • 南非
        • 其他非洲地区
    • 亚太地区
      • 按国家/地区
        • 澳洲
        • 中国
        • 印度
        • 印尼
        • 日本
        • 菲律宾
        • 泰国
        • 越南
        • 亚太其他地区
    • 欧洲
      • 按国家/地区
        • 法国
        • 德国
        • 义大利
        • 荷兰
        • 俄罗斯
        • 西班牙
        • 土耳其
        • 英国
        • 其他欧洲地区
    • 中东
      • 按国家/地区
        • 伊朗
        • 沙乌地阿拉伯
        • 其他中东地区
    • 北美洲
      • 按国家/地区
        • 加拿大
        • 墨西哥
        • 我们
        • 北美其他地区
    • 南美洲
      • 按国家/地区
        • 阿根廷
        • 巴西
        • 其他南美洲

第六章 竞争情势

  • 关键策略倡议
  • 市占率分析
  • 公司概况
  • 公司简介
    • Koppert Biological Systems BV
    • BASF SE
    • Bayer AG
    • Syngenta Group
    • BioFirst Group
    • Valent BioSciences（Sumitomo Chemical Co., Ltd.）
    • Certis Biologicals（Mitsui and Co.）
    • Andermatt Group AG
    • Novonesis
    • Pro Farm（Bioceres Crop Solutions）
    • Bioline AgroSciences Ltd（InVivo Group）
    • De Sangosse
    • T Stanes and Company Limited（Amalgamations Group）
    • Biobee Ltd

第七章：CEO们需要思考的关键策略问题

简介目录
Product Code: 50344

The biological control market was valued at USD 4.01 billion in 2025 and estimated to grow from USD 4.29 billion in 2026 to reach USD 5.98 billion by 2031, at a CAGR of 6.89% during the forecast period (2026-2031).

Biological Control - Market - IMG1

Cost-effective microbial platforms, automation in insect rearing, and mounting regulatory pressure against conventional pesticides are accelerating adoption across major crop systems. Asia-Pacific drives global demand through expansive government subsidy programs, while Africa's aggressive food-security initiatives anchor the fastest growth outlook. Rapid pest resistance to synthetic chemistries and rising consumer preference for certified-organic produce continue to expand addressable acreage. Meanwhile, fermentation innovation and longer shelf-life formulations are narrowing historical performance gaps with chemical alternatives, strengthening the competitive position of biological inputs.

Global Biological Control Market Trends and Insights

Stringent bans on high-toxicity synthetic pesticides

Regulators continue to phase out high-risk chemistries, catalyzing immediate substitution opportunities for biological solutions. The European Union Farm-to-Fork Strategy mandates a 50% cut in chemical pesticide use by 2030, and the United States Environmental Protection Agency (EPA) has canceled more than 40 active ingredients since 2024. Brazil and India issued parallel restrictions in 2024, increasing near-term acreage available for biocontrol adoption. These policy moves encourage manufacturers to accelerate product launches and spur farmers to recalibrate crop-protection programs toward IPM frameworks.

Rising global demand for certified-organic produce

Global organic food sales climbed to USD 134 billion in 2024, with annual growth above 8% in the United States, Germany, and China. Supermarkets enforce residue-free supplier policies, pushing growers to adopt biological inputs that preserve certification. Premium farm-gate prices, typically 20-40% above conventional produce, offset higher biological agent costs and facilitate deeper penetration in high-value horticulture.

Short commercial shelf-life for many living products

Most macrobial biocontrol agents maintain viability for only 2-4 weeks even under refrigerated conditions, necessitating expensive cold-chain logistics systems and significantly restricting market penetration in regions experiencing unreliable electricity supply. While recent technological advances in encapsulation methods and cryoprotectant formulations have demonstrated the potential to double product shelf-life in pilot studies, these improvements still fall considerably short of matching the multi-year stability achieved by synthetic chemical alternatives.

Other drivers and restraints analyzed in the detailed report include:

  1. Accelerating pest resistance to conventional chemistries
  2. Government subsidies for IPM adoption and biological inputs
  3. Protracted multi-agency registration timelines

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Macrobials maintained their commanding 97.25% market share of the biological control market in 2025, reflecting decades of commercial development in beneficial insect production and established distribution networks that serve agricultural markets worldwide. The segment's dominance stems from proven efficacy in field applications and farmer familiarity with release protocols for predatory insects and parasitoids. Entomopathogenic nematodes represent the largest macrobial category, particularly effective against soil-dwelling pests in row crop systems. At the same time, predators and parasitoids excel in greenhouse environments where environmental conditions can be controlled.

Microbials are emerging as the growth engine with an 8.59% forecast CAGR through 2031. The shift toward microbials reflects technological advances in fermentation processes and formulation stability that are addressing historical limitations of bacterial and fungal biocontrol agents. Recent regulatory approvals for multi-strain microbial products are expanding application possibilities, particularly in high-value horticultural crops, where precision application justifies premium pricing. Other microbials, including viral and protozoan agents, remain niche applications but show promise for specific pest complexes where conventional approaches have failed. The form segmentation evolution indicates how different biological mechanisms are finding optimal commercial applications based on target pest biology and crop production systems.

The Biological Control Market Report is Segmented by Form (Macrobials, Microbials), Crop Type (Cash Crops, Horticultural Crops, and Row Crops), and Geography (Africa, Asia-Pacific, Europe, Middle East, North America, and South America). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).

Geography Analysis

Asia-Pacific commanded 66.80% of the biological control market in 2025, reflecting 165 million hectares under mandatory pesticide-reduction mandates in China and generous subsidies in India. China's National Action Plan for Pesticide Reduction targets a 40% cut in chemical use by 2030 and funds provincial training centers that demonstrate field-scale parasitoid releases. India's National Mission for Sustainable Agriculture finances 30 regional production hubs supplying microbials to smallholder cooperatives.

Africa posts the fastest 10.44% CAGR to 2031 as governments combine food-security goals with donor-funded sustainability programs. Nigeria's public-private initiative plans to serve 2 million smallholders by 2027, while Egypt builds 15 local production sites to lessen import dependence. Local capacity enables fresher products and circumvents cold-chain gaps.

Europe and North America register steady gains supported by the European Union Farm-to-Fork Strategy and premium organic sectors. The biological control market size for Europe benefits from CAP reimbursements that cover up to 70% of product costs. North America leans on a USD 134 billion organic retail channel that secures premiums of 20-40% above conventional produce, reinforcing demand for biological crop protection.

  1. Koppert Biological Systems B.V.
  2. BASF SE
  3. Bayer AG
  4. Syngenta Group
  5. BioFirst Group
  6. Valent BioSciences (Sumitomo Chemical Co., Ltd.)
  7. Certis Biologicals (Mitsui and Co.)
  8. Andermatt Group AG
  9. Novonesis
  10. Pro Farm (Bioceres Crop Solutions)
  11. Bioline AgroSciences Ltd (InVivo Group)
  12. De Sangosse
  13. T Stanes and Company Limited (Amalgamations Group)
  14. Biobee Ltd

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study
  • 1.3 Research Methodology

2 REPORT OFFERS

3 EXECUTIVE SUMMARY AND KEY FINDINGS

4 KEY INDUSTRY TRENDS

  • 4.1 Area Under Organic Cultivation
  • 4.2 Per Capita Spending On Organic Products
  • 4.3 Regulatory Framework
    • 4.3.1 Australia
    • 4.3.2 Brazil
    • 4.3.3 Canada
    • 4.3.4 China
    • 4.3.5 France
    • 4.3.6 Germany
    • 4.3.7 India
    • 4.3.8 Indonesia
    • 4.3.9 Italy
    • 4.3.10 Japan
    • 4.3.11 Mexico
    • 4.3.12 Netherlands
    • 4.3.13 Philippines
    • 4.3.14 Russia
    • 4.3.15 Spain
    • 4.3.16 Thailand
    • 4.3.17 Turkey
    • 4.3.18 United Kingdom
    • 4.3.19 United States
    • 4.3.20 Vietnam
  • 4.4 Value Chain and Distribution Channel Analysis
  • 4.5 Market Drivers
    • 4.5.1 Stringent bans on high-toxicity synthetic pesticides
    • 4.5.2 Rising global demand for certified-organic produce
    • 4.5.3 Accelerating pest resistance to conventional chemistries
    • 4.5.4 Government subsidies for IPM adoption and biological inputs
    • 4.5.5 Insect-rearing automation slashing cost of macrobials
    • 4.5.6 Breakthrough predatory bacterial platforms targeting phytopathogens
  • 4.6 Market Restraints
    • 4.6.1 Short commercial shelf-life for many living products
    • 4.6.2 Protracted multi-agency registration timelines
    • 4.6.3 Limited sterile fermentation capacity for next-gen microbials
    • 4.6.4 Micro-climate-driven efficacy variability undermining farmer confidence

5 MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)

  • 5.1 Form
    • 5.1.1 Macrobials
      • 5.1.1.1 By Organism
        • 5.1.1.1.1 Entamopathogenic Nematodes
        • 5.1.1.1.2 Parasitoids
        • 5.1.1.1.3 Predators
    • 5.1.2 Microbials
      • 5.1.2.1 By Organism
        • 5.1.2.1.1 Bacterial Biocontrol Agents
        • 5.1.2.1.2 Fungal Biocontrol Agents
        • 5.1.2.1.3 Other Microbials
  • 5.2 Crop Type
    • 5.2.1 Cash Crops
    • 5.2.2 Horticultural Crops
    • 5.2.3 Row Crops
  • 5.3 Region
    • 5.3.1 Africa
      • 5.3.1.1 By Country
        • 5.3.1.1.1 Egypt
        • 5.3.1.1.2 Nigeria
        • 5.3.1.1.3 South Africa
        • 5.3.1.1.4 Rest of Africa
    • 5.3.2 Asia-Pacific
      • 5.3.2.1 By Country
        • 5.3.2.1.1 Australia
        • 5.3.2.1.2 China
        • 5.3.2.1.3 India
        • 5.3.2.1.4 Indonesia
        • 5.3.2.1.5 Japan
        • 5.3.2.1.6 Philippines
        • 5.3.2.1.7 Thailand
        • 5.3.2.1.8 Vietnam
        • 5.3.2.1.9 Rest of Asia-Pacific
    • 5.3.3 Europe
      • 5.3.3.1 By Country
        • 5.3.3.1.1 France
        • 5.3.3.1.2 Germany
        • 5.3.3.1.3 Italy
        • 5.3.3.1.4 Netherlands
        • 5.3.3.1.5 Russia
        • 5.3.3.1.6 Spain
        • 5.3.3.1.7 Turkey
        • 5.3.3.1.8 United Kingdom
        • 5.3.3.1.9 Rest of Europe
    • 5.3.4 Middle East
      • 5.3.4.1 By Country
        • 5.3.4.1.1 Iran
        • 5.3.4.1.2 Saudi Arabia
        • 5.3.4.1.3 Rest of Middle East
    • 5.3.5 North America
      • 5.3.5.1 By Country
        • 5.3.5.1.1 Canada
        • 5.3.5.1.2 Mexico
        • 5.3.5.1.3 United States
        • 5.3.5.1.4 Rest of North America
    • 5.3.6 South America
      • 5.3.6.1 By Country
        • 5.3.6.1.1 Argentina
        • 5.3.6.1.2 Brazil
        • 5.3.6.1.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Key Strategic Moves
  • 6.2 Market Share Analysis
  • 6.3 Company Landscape
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 Koppert Biological Systems B.V.
    • 6.4.2 BASF SE
    • 6.4.3 Bayer AG
    • 6.4.4 Syngenta Group
    • 6.4.5 BioFirst Group
    • 6.4.6 Valent BioSciences (Sumitomo Chemical Co., Ltd.)
    • 6.4.7 Certis Biologicals (Mitsui and Co.)
    • 6.4.8 Andermatt Group AG
    • 6.4.9 Novonesis
    • 6.4.10 Pro Farm (Bioceres Crop Solutions)
    • 6.4.11 Bioline AgroSciences Ltd (InVivo Group)
    • 6.4.12 De Sangosse
    • 6.4.13 T Stanes and Company Limited (Amalgamations Group)
    • 6.4.14 Biobee Ltd

7 KEY STRATEGIC QUESTIONS FOR AGRICULTURAL BIOLOGICALS CEOS